openPR Logo
Press release

Renal Artery Stenosis Treatment Market Intelligence Report Offers Growth Prospects 2018-2028

12-05-2018 05:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Renal Artery Stenosis Treatment Market Intelligence Report

Renal artery stenosis is the narrowing of the renal artery that carries blood to the kidneys. The narrowing of the renal artery obstructs blood flow, resulting in renovascular hypertension, high blood pressure, and kidney damage. Atherosclerosis and fibromuscular dysplasia are the major causes of renal artery stenosis. Atherosclerosis is the most common cause of renal artery stenosis in the older age group. 90% renal artery stenosis is caused by atherosclerosis. Atherosclerosis is a disease in which the inside of the artery narrows due to plaque buildup of cholesterol and fats. Atherosclerosis is associated with the narrowing, clogging, and hardening of the renal arteries. Fibromuscular dysplasia is commonly seen in the young age group, and predominantly affects women. Fibromuscular dysplasia is a rare cause of renal artery stenosis, in which the arterial wall cells undergo abnormal growth. Chronic kidney disease, coronary artery disease, peripheral vascular disease, and stroke are the possible complications associated with renal artery stenosis. For renal artery stenosis treatment, doctors mostly prescribe medication to lower cholesterol levels and high blood pressure. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers are the most common blood pressure lowering medications used for renal artery stenosis treatment. Diuretic, beta blockers, and calcium channel blockers are other common drugs used for renal artery stenosis treatment.

The growing prevalence of atherosclerosis is expected to be a major factor driving the growth of the renal artery stenosis treatment market over the forecast period. The worldwide prevalence of atherosclerotic renal artery stenosis is 0.5% in the overall population, and 5-4% among patients with chronic kidney disease. Increasing peripheral atrial disease and cholesterol problems are the other factors expected to boost the demand for renal artery stenosis treatment drugs. Inactive lifestyles, unhealthy eating habits, irregular eating timings, and lack of exercise are attributed to the growing prevalence of renal artery stenosis. Increasing hypertension problems among the general population and increasing older population are other factors expected to fuel the growth of the renal artery stenosis treatment market. Increasing diagnosis rates due to screening programs, favorable Medicare policies, increasing and healthcare expenditures are other reasons for the growth of the renal artery stenosis treatment market. The side effects associated with some renal artery stenosis treatment medications and no proper treatment available for renal artery stenosis associated with fibromuscular dysplasia are some of the factors expected to restrain the renal artery stenosis treatment market.

Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1489

The global market for renal artery stenosis treatment is expected to witness moderate growth over the forecast period. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers Renal Artery Stenosis Treatment are expected to contribute major revenue share in the renal artery stenosis treatment market. Among both of the indications, the atherosclerosis segment is expected to lead in the global renal artery stenosis treatment market over the forecast period. The retail pharmacies distribution channel segment in is expected to contribute a high share in the global renal artery stenosis treatment market, as it is the most accessible channel and a majority of patients are recommended for outpatient treatment.

Geographically, the global renal artery stenosis treatment market is segmented into America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global renal artery stenosis treatment market, owing to the high prevalence of atherosclerosis among the older population. Europe Renal Artery Stenosis Treatment market is expected to have the second-largest share in the global renal artery stenosis treatment market throughout the forecast period, owing to high awareness regarding health-related problems and increasing healthcare screening programs. The renal artery stenosis treatment market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to increasing healthcare expenditure and increasing healthcare facilities.

Examples of some of the key players operating in the global renal artery stenosis treatment market are Abbott Laborites, Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., and others.

Report Overview at https://www.factmr.com/report/1489/renal-artery-stenosis-treatment-market

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Artery Stenosis Treatment Market Intelligence Report Offers Growth Prospects 2018-2028 here

News-ID: 1419767 • Views:

More Releases from Fact.MR

Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players include Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharmaceuticals, IBA Group, IBA Radiopharma Solutions, Lantheus Medical Imaging
10-01-2025 | Health & Medicine
Fact.MR
Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players inclu …
The global muscle stimulators market is set for significant expansion, with its valuation expected to increase from USD 1.43 billion in 2025 to USD 2.92 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's robust trajectory is driven by rising awareness of health and fitness, technological advancements in rehabilitation devices, and the increasing prevalence
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., Cadwell Industries, Inc., Compumedics Ltd., GlaxoSmithKline, Inc., Hill-Rom Holdings
10-01-2025 | Health & Medicine
Fact.MR
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Be …
Fact.MR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; Salesforce; SAS; Oracle; Acoustic; Act-on Software; SendinBlue
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; …
The global marketing automation market is experiencing robust growth, valued at USD 6.83 billion in 2024 and forecasted to reach USD 26.68 billion by 2034. This expansion reflects a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2024 to 2034. The surge is primarily driven by the escalating demand for targeted advertising, enhanced user retention, and data-backed strategies in digital marketing channels. As internet penetration and
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, Driven by Digital Transformation and Hybrid Work Trends
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, …
The global Integrated Workplace Management System (IWMS) market is experiencing significant growth, with projections indicating an increase from approximately USD 4 billion in 2024 to USD 10.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.2% over the period from 2025 to 2034. This expansion is attributed to the rising demand for automation in facility management, the adoption of digital workplace solutions, and the need for efficient

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period